Literature DB >> 382240

Non-Hodgkin lymphoma of the lungs.

J P Balikian, P G Herman.   

Abstract

Twenty-seven consecutive cases of pulmonary involvement by non-Hodgkin in lymphoma, including 2 cases of primary pulmonary disease, were anlyzed. The radiological manifestations of illness were divided into (a) nodular (subpleural, deep parenchymal, or perihilar), (b) pneumonic-alveolar (segmental or lobar), (c) bronchovascular-lymphangitic (central bronchovascular or diffuse lymphangitic), and (d) miliary-hematogenous. Histiocytic lymphoma was associated with infiltration of rapid onset in 6, cavitating nodules in 2, and diffuse lymphangitic dissemination in 9. Of 16 patients with lymphocytic lymphoma, 7 had lobar or segmental alveolar involvement.

Entities:  

Mesh:

Year:  1979        PMID: 382240     DOI: 10.1148/132.3.569

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors.

Authors:  S Terui; T Terauchi; H Abe; H Fukuma; Y Beppu; K Chuman; R Yokoyama
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

2.  I-123 IMP scintigraphy in two patients with primary pulmonary malignant lymphoma.

Authors:  K Suga; K Nishigauchi; M Sadanaga; N Kume; H Uchisako; T Matsumoto; T Nakanishi
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

3.  Respiratory distress as primary symptom of relapse in a patient with non-Hodgkin lymphoma.

Authors:  A D Ho; M Kleckow; E Rix; W Hunstein
Journal:  Blut       Date:  1985-10

Review 4.  [Lung involvement in hematologic systemic diseases].

Authors:  S-S Stecher; S Lippl; H J Stemmler; J Schreiber
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

5.  Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.

Authors:  Chunji Chen; Shijie Fu; Qiming Ni; Wang Yiyang; Xufeng Pan; Jiao Jing; Heng Zhao; Wang Rui
Journal:  Med Sci Monit       Date:  2019-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.